MONKEYPOX (MPOX) DIAGNOSIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Global monkeypox (Mpox) diagnosis market is estimated to be valued at USD 1.97 Bn in 2024 and is expected to reach USD 2.62 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031. Global monkeypox virus (MPXV) outbreak in 2022 highlighted the need for prompt diagnosis of the disease. Monkeypox is a rare viral zoonotic disease that is caused by infection with the Monkeypox virus. The disease presents clinically with fever, rash, and swollen lymph nodes and is usually self-limiting. However, severe cases can occur. Timely diagnosis is crucial to limit human-to-human transmission through isolation of infected patients and contact tracing.
Market Dynamics
Global monkeypox (Mpox) diagnosis market is driven by the ongoing outbreak of monkeypox cases globally. The sustained spread of monkeypox to new regions and countries where it is not usually found has prompted greater testing needs. Introduction of novel diagnostics technologies such as multiplex polymerase chain reaction tests that can detect monkeypox alongside other orthopox viruses is boosting adoption. However, low disease awareness among the public and healthcare workers in some parts of the world poses a challenge for accurate diagnosis. Increasing research activities for the development of rapid point-of-care tests provide lucrative opportunities for market players in the long run.
Key Features of the Study
- This report provides in-depth analysis of the global monkeypox (Mpox) diagnosis market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global monkeypox (Mpox) diagnosis market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Aegis Sciences Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, QIAGEN, Mayo Clinic Laboratories, Chembio Diagnostics, Inc., Sonora Quest Laboratories, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), CerTest Biotech, GenMark Diagnostics, Inc., Roche Diagnostics, Abbott Laboratories, Hologic, Inc., Siemens Healthineers, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., and Meridian Bioscience, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global monkeypox (Mpox) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monkeypox (Mpox) diagnosis market
Market Segmentation
Table of Contents
*Browse 32 market data tables and 28 figures on 'Monkeypox (Mpox) Diagnosis Market' - Global forecast to 2031
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
